Tomasovic et al v. Endo Pharmaceuticals, Inc. et al

Northern District of Illinois, ilnd-1:2016-cv-06231

STIPULATION of Dismissal with Prejudice Pursuant to Rule FRCP 41

Interested in this case?

Current View

Full Text

Case: 1:16-cv-06231 Document #: 10 Filed: 12/12/19 Page 1 of 2 PageID #:19 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION In re: TESTOSTERONE) MDL No. 2545 REPLACEMENT THERAPY) PRODUCTS LIABILITY LITIGATION) STIPULATION OF DISMISSAL) WITH PREJUDICE PURSUANT TO This document relates to:) RULE 41 VALENT and ANNA TOMASOVIC)) Case No.: 1:16-cv-06231 IT IS HEREBY STIPULATED AND AGREED by the parties, through their respective counsel indicated below, that pursuant to Rule 41(a)(1)(A)(ii) of the Federal Rules of Civil Procedure, the above captioned action is hereby dismissed with prejudice as to all Defendants, with each party to bear its own costs and attorneys' fees. PLAINTIFFS DEFENDANTS /s/ Dennis J. Canty______________ /s/ Andrew Keith Solow Dennis J. Canty Andrew Keith Solow Kaiser Gornick LLP Arnold & Porter Kaye Scholer LLP 100 Pringle Avenue, Suite 310 250 West 55th Street Walnut Creek, CA 94596 New York, NY 10019-9710 Tel: (415) 857-7400 (212) 836-7740 Fax: (415) 857-7499 Email: Attorney for Plaintiffs Attorneys for Endo Pharmaceuticals Inc. and Auxilium Pharmaceuticals, Inc. December 12, 2019 Case: 1:16-cv-06231 Document #: 10 Filed: 12/12/19 Page 2 of 2 PageID #:19 CERTIFICATE OF SERVICE I, Andrew K. Solow, hereby certify that on December 12, 2019, the foregoing document was filed via the Court's CM/ECF system, which will automatically serve and send email notification of such filing to all registered attorneys of record. /s/ Andrew K. Solow